CYTK vs. SCHG

Last updated Apr 2, 2026

Compare and contrast key facts about Cytokinetics, Incorporated (CYTK) and Schwab U.S. Large-Cap Growth ETF (SCHG).

SCHG is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. It was launched on Dec 11, 2009.

Performance

CYTK vs. SCHG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cytokinetics, Incorporated (CYTK) and Schwab U.S. Large-Cap Growth ETF (SCHG). The values are adjusted to include any dividend payments, if applicable.

CYTK vs. SCHG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CYTK Cytokinetics, Incorporated	4.83%	35.08%	-43.66%	82.21%	0.53%	119.35%	95.85%	67.88%	-22.45%	-32.92%
SCHG Schwab U.S. Large-Cap Growth ETF	-9.73%	17.50%	34.95%	50.10%	-31.80%	28.11%	39.14%	36.02%	-1.36%	28.05%

Returns By Period

In the year-to-date period, CYTK achieves a 4.83% return, which is significantly higher than SCHG's -9.73% return. Over the past 10 years, CYTK has outperformed SCHG with an annualized return of 24.93%, while SCHG has yielded a comparatively lower 16.95% annualized return.

CYTK

• 1D: 1.06%
• 1M: 8.43%
• YTD: 4.83%
• 6M: 19.29%
• 1Y: 77.63%
• 3Y*: 23.70%
• 5Y*: 22.20%
• 10Y*: 24.93%

SCHG

• 1D: 0.96%
• 1M: -4.46%
• YTD: -9.73%
• 6M: -8.15%
• 1Y: 17.00%
• 3Y*: 22.30%
• 5Y*: 12.76%
• 10Y*: 16.95%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CYTK vs. SCHG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CYTK

CYTK Risk / Return Rank: 79
CYTK Sharpe Ratio Rank: 79
CYTK Sortino Ratio Rank: 82
CYTK Omega Ratio Rank: 78
CYTK Calmar Ratio Rank: 78
CYTK Martin Ratio Rank: 76

SCHG

SCHG Risk / Return Rank: 41
SCHG Sharpe Ratio Rank: 39
SCHG Sortino Ratio Rank: 43
SCHG Omega Ratio Rank: 42
SCHG Calmar Ratio Rank: 40
SCHG Martin Ratio Rank: 39

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CYTK vs. SCHG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cytokinetics, Incorporated (CYTK) and Schwab U.S. Large-Cap Growth ETF (SCHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CYTK	SCHG	Difference
Sharpe ratio Return per unit of total volatility	1.25	0.76	+0.49
Sortino ratio Return per unit of downside risk	2.28	1.24	+1.04
Omega ratio Gain probability vs. loss probability	1.28	1.17	+0.11
Calmar ratio Return relative to maximum drawdown	2.16	1.09	+1.06
Martin ratio Return relative to average drawdown	5.07	3.71	+1.36
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CYTK vs. SCHG - Sharpe Ratio Comparison

The current CYTK Sharpe Ratio is 1.25, which is higher than the SCHG Sharpe Ratio of 0.76. The chart below compares the historical Sharpe Ratios of CYTK and SCHG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CYTK	SCHG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.25	0.76	+0.49
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.32	0.57	-0.26
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.37	0.79	-0.42
Sharpe Ratio (All Time) Calculated using the full available price history	-0.02	0.79	-0.82

Correlation

The correlation between CYTK and SCHG is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CYTK vs. SCHG - Dividend Comparison

CYTK has not paid dividends to shareholders, while SCHG's dividend yield for the trailing twelve months is around 0.43%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CYTK Cytokinetics, Incorporated	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SCHG Schwab U.S. Large-Cap Growth ETF	0.43%	0.36%	0.39%	0.46%	0.55%	0.42%	0.52%	0.82%	1.27%	1.01%	1.04%	1.22%

Drawdowns

CYTK vs. SCHG - Drawdown Comparison

The maximum CYTK drawdown since its inception was -97.09%, which is greater than SCHG's maximum drawdown of -34.59%. Use the drawdown chart below to compare losses from any high point for CYTK and SCHG.

Drawdown Indicators

	CYTK	SCHG	Difference
Max Drawdown Largest peak-to-trough decline	-97.09%	-34.59%	-62.50%
Max Drawdown (1Y) Largest decline over 1 year	-30.48%	-16.41%	-14.07%
Max Drawdown (5Y) Largest decline over 5 years	-72.39%	-34.59%	-37.80%
Max Drawdown (10Y) Largest decline over 10 years	-72.39%	-34.59%	-37.80%
Current Drawdown Current decline from peak	-38.36%	-12.51%	-25.85%
Average Drawdown Average peak-to-trough decline	-76.37%	-5.22%	-71.15%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.98%	4.84%	+8.14%

Volatility

CYTK vs. SCHG - Volatility Comparison

Cytokinetics, Incorporated (CYTK) has a higher volatility of 11.36% compared to Schwab U.S. Large-Cap Growth ETF (SCHG) at 6.77%. This indicates that CYTK's price experiences larger fluctuations and is considered to be riskier than SCHG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CYTK	SCHG	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.36%	6.77%	+4.59%
Volatility (6M) Calculated over the trailing 6-month period	30.73%	12.54%	+18.19%
Volatility (1Y) Calculated over the trailing 1-year period	62.65%	22.45%	+40.20%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	69.91%	22.31%	+47.60%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	67.84%	21.51%	+46.33%